Developemental Research Program

发展研究计划旨在开发创新的前列腺癌转化 research.因此，它支持新颖的转化研究项目或具有一定潜力的研究项目 为今后的转化研究提供科学基础。这一计划对我们来说非常重要。 前列腺孢子的成功，因为它使一个积极的立场，在确定和支持创新 假设驱动的研究。这种支持的可用性也为创造性提供了刺激， 研究共同体，鼓励基础科学家和翻译人员互动的工具 研究人员，并有机会扩大研究范围的孢子追求新的线索 基于发现和/或出现的机会。我们在申请中要求10万美元， 支持这个方案。此外，马约还将为发展研究提供额外的5万美元。 计划（见马约首席执行官兼理事会主席Hugh Smith博士的承诺书 诊所，罗切斯特，和副总裁的马约基金会）。因此，我们计划拨款15万元， 发展研究计划。

The Developmental Research Program is designed to develop innovative prostate cancer translational research. As such, it supports novel translational research projects or research projects with definite potential to provide a scientific base for future translational research. This program is of great importance to the success of the Prostate SPORE because it enables a proactive stance in identifying and supporting innovative hypothesis-driven research. The availability of this support also provides a stimulus for creativity in the research community, a vehicle for encouraging the interaction of basic scientists and translational investigators, and an opportunity for expanding the research spectrum of the SPORE by pursuing new leads based on discoveries and/or opportunities that arise. We have requested $100,000 in the application to support this program. In addition Mayo will provide an additional $50,000 for the Developmental Research Program (See letter of commitment from Dr. Hugh Smith, CEO and Chair of the Board of Governors of Mayo Clinic, Rochester, and Vice President of the Mayo Foundation). Thus, we plan to commit a total of $150,000 to the Developmental Research Program.